These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 989383)

  • 1. [Receptor-blockade and receptor-hypersensitivity following neuroleptic treatment (author's transl)].
    Nielsen IM; Christensen AV; Hyttel J
    Arzneimittelforschung; 1976; 26(6):1090-2. PubMed ID: 989383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the supersensitivity of dopamine receptors, induced by neuroleptics.
    Christensen AV; Fjalland B; Nielsen IM
    Psychopharmacology (Berl); 1976 Jul; 48(1):1-6. PubMed ID: 9655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. A hypothesis on their mode of interaction with the central dopamine receptor.
    Humber LG; Bruderlein FT; Voith K
    Mol Pharmacol; 1975 Nov; 11(6):833-40. PubMed ID: 1239657
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of anticholinergics and clozapine on the activation of the striatal dopaminergic system in the rat by haloperidol. Pharmacological findings (author's transl)].
    Sayers AC; Bürki HR
    Arzneimittelforschung; 1976; 26(6):1092-3. PubMed ID: 989384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blockade of the dopamine receptor: a possible mechanism of action of antipsychotic drugs (author's transl)].
    Karobath ME
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Jul; 8(4):151-61. PubMed ID: 1233518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of direct and indirect dopamine agonists on the induction of gnawing in C57Bl/6J mice.
    Tirelli E; Witkin JM
    J Pharmacol Exp Ther; 1995 Apr; 273(1):7-15. PubMed ID: 7714815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic supersensitivity: influence of dopamine agonists and drugs used for the treatment of tardive dyskinesia.
    Christensen AV; Nielsen IM
    Adv Biochem Psychopharmacol; 1980; 24():341-9. PubMed ID: 6105784
    [No Abstract]   [Full Text] [Related]  

  • 8. Behavioural correlates to the dopamine D-1 and D-2 antagonists.
    Christensen AV; Arnt J; Hyttel J; Svendsen O
    Pol J Pharmacol Pharm; 1984; 36(2-3):249-64. PubMed ID: 6147830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proceedings: Interaction of neuroleptic and cholinergic drugs with central dopaminergic mechanisms.
    Kelly P; Miller RJ; Sahakian B
    Br J Pharmacol; 1974 Nov; 52(3):430P-431P. PubMed ID: 4477511
    [No Abstract]   [Full Text] [Related]  

  • 10. Blockade of central dopaminergic receptors of morphine: effect of haloperidol, apomorphine or benztropine.
    Puri SK; Reddy C; Lal H
    Res Commun Chem Pathol Pharmacol; 1973 Mar; 5(2):389-401. PubMed ID: 4735501
    [No Abstract]   [Full Text] [Related]  

  • 11. Action of dopamine receptor agonists in forebrain and hypothalamus: rotational behavior, ovulation, and dopamine turnover.
    Fuxe K; Agnati LF; Corrodi H; Everitt BJ; Hökfelt T; Löfström A; Ungerstedt U
    Adv Neurol; 1975; 9():223-42. PubMed ID: 1146654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of flupenthixol and flupenthixol-decanoate on methylphenidate and apomorphine-induced compulsive gnawing in mice.
    Christensen AV; Moller Nielsen I
    Psychopharmacologia; 1974 Jan; 34(2):119-26. PubMed ID: 4856369
    [No Abstract]   [Full Text] [Related]  

  • 13. gamma-Butyrolactone effects on behavior induced by dopamine agonists.
    Ellinwood EH; Gonzalez AE; Dougherty GG
    Biol Psychiatry; 1983 Sep; 18(9):1023-32. PubMed ID: 6685535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some central effects of opioid antagonists. Part I.
    Skorupska M; Langwiński R
    Pol J Pharmacol Pharm; 1989; 41(5):401-11. PubMed ID: 2577060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of the brain dopamine system in mice carrying the quaking neurological mutation].
    Nikulina IuA; Skrinskaia IuA; Popova NK
    Biull Eksp Biol Med; 1988 Aug; 106(8):212-4. PubMed ID: 3262000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amantadine and apomorphine: interactions on striatal dopamine receptors.
    Cox B
    Proc West Pharmacol Soc; 1975; 18():162-7. PubMed ID: 1237137
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway.
    Chopin P; Colpaert FC; Marien M
    J Pharmacol Exp Ther; 1999 Feb; 288(2):798-804. PubMed ID: 9918591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC; Fukushiro DF; Helfer DC; Callegaro-Filho D; Trombin TF; Zanlorenci LH; Sanday L; Silva RH; Frussa-Filho R
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of narcotic analgesics with neuroleptics on behavioral measures of dopaminergic activity.
    Lal H; Gianutsos G; Puri SK
    Life Sci; 1975 Jul; 17(1):29-34. PubMed ID: 238089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.